Perfusion curve f (t) analysis of breast cancer by contrast-enhanced ultrasonography
Liang Guo, Zhigang Liu, Pei-Hua Han, Quan Yuan, Yu He, Jun Li
Abstract
Liang Guo, Zhigang Liu, Pei-Hua Han, Quan Yuan, Yu He, Jun Li
Abstract
BACKGROUND: Imaging the perfusion of contrast media in breast tumors may allow improved diagnosing and treating breast cancer. PURPOSE: To compare the perfusion curve f (t) characteristics of contrast-enhanced ultrasonography in benign and malignant breast tumors. MATERIAL AND METHODS: Patients with breast tumors (n = 87) were evaluated with contrast-enhanced ultrasonography and the perfusion curve f (t) parameters were calculated using Sonoliver(®) software to compare analysis (tumor) and reference (normal) tissue areas. Differences between breast and breast tumors were assessed. RESULTS: Compared to benign tumors, malignant tumors had faster enhancement time and a shorter mean transit time (all P values < 0.05). The intensity of the signal was also greater for malignant compared with benign tumors. CONCLUSION: Perfusion curve f (t) parameter measurements can distinguish differences in vascular flow between malignant and benign breast tumors and may provide a new quantitative indicator of breast tumor.
OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
BACKGROUND: Imaging the perfusion of contrast media in breast tumors may allow improved diagnosing and treating breast cancer. PURPOSE: To compare the perfusion curve f (t) characteristics of contrast-enhanced ultrasonography in benign and malignant breast tumors. MATERIAL AND METHODS: Patients with breast tumors (n = 87) were evaluated with contrast-enhanced ultrasonography and the perfusion curve f (t) parameters were calculated using Sonoliver(®) software to compare analysis (tumor) and reference (normal) tissue areas. Differences between breast and breast tumors were assessed. RESULTS: Compared to benign tumors, malignant tumors had faster enhancement time and a shorter mean transit time (all P values < 0.05). The intensity of the signal was also greater for malignant compared with benign tumors. CONCLUSION: Perfusion curve f (t) parameter measurements can distinguish differences in vascular flow between malignant and benign breast tumors and may provide a new quantitative indicator of breast tumor.
Key concepts: Medicine, Perfusion, Breast cancer, Radiology, Ultrasonography, Area under the curve, Contrast (vision), Perfusion scanning